We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Discovery Solutions for Cell and Gene Therapy content piece image
Product
Advertisement

Discovery Solutions for Cell and Gene Therapy

As a leading manufacturer of recombinant proteins and other critical reagents to support the development of biomedicine, ACROBiosystems is proud to stand by you in the CGT journey.
GDNF: A Neurotrophic and Neuroprotective Factor content piece image
Product
Advertisement

GDNF: A Neurotrophic and Neuroprotective Factor

Glial cell line-derived neurotrophic factor (GDNF) plays a vital role in promoting motor neuron survival and axon outgrowth. It is being evaluated in clinical trials as a potential therapeutic for Parkinson’s disease. GFL-like drugs are also being developed to treat disorders such as neuropathic pain and addiction.
Premium Recombinant Cytokines content piece image
Product
Advertisement

Premium Recombinant Cytokines

Sino Biological has newly launched a number of recombinant cytokines, including IL21, TNF-alpha, and IL-1 beta.

Sino Biological has developed a panel of high-quality recombinant cytokines and receptor proteins as well as antibodies to support the study.
Streamline Your Immuno-Oncology Workflow With Simple Plex Immunoassays  content piece image
Product
Advertisement

Streamline Your Immuno-Oncology Workflow With Simple Plex Immunoassays

Sample-conserving Simple Plex assays deliver consistent and accurate data in real-time, every time.
Get New, Physiologically Relevant Insights From 3D Human Tissue Models Quickly, Easily, and Affordably content piece image
Product
Advertisement

Get New, Physiologically Relevant Insights From 3D Human Tissue Models Quickly, Easily, and Affordably

Three-dimensional (3D) cell models are more biologically relevant than two-dimensional cell cultures as they more closely represent the tissue microenvironments, cell-to-cell interactions, and biological processes that occur in vivo. But how can you accurately and consistently generate more predictive data, while maintaining high-throughput and reducing cost?
Selection Guide for EVOS Objectives content piece image
Product
Advertisement

Selection Guide for EVOS Objectives

A range of microscope objectives are available and the optimal choice for a given sample and application will depend on several technical factors. Prices can vary from a few hundred dollars to several thousand and in many cases is a real consideration as well. By an understanding of the factors that influence image quality (contrast, signal-to-noise, resolution, etc.), as well as the terms that describe objective classes and types, well-informed decisions can be made and data appropriate for the purpose of the experiment more easily generated.
New StarBright Dyes for Flow Cytometry content piece image
Product
Advertisement

New StarBright Dyes for Flow Cytometry

New, Bright, Fluorescent Nanoparticles Developed for Flow Cytometry. Bio-Rad has now launched ten StarBright Dyes, including StarBright Blue 700, eight StarBright Violet Dyes, and the latest in the range StarBright UltraViolet 400, with many more due to be launched over the coming year.
Save Time and Sample – Automate ELISAs With Ella™ content piece image
Product
Advertisement

Save Time and Sample – Automate ELISAs With Ella™

Eliminate the challenges that come with manual ELISAs. Meet Ella™ — your next generation automated ELISA instrument from Bio-Techne. In just 90 minutes you get highly reproducible validated assay data with no manual steps.
Monitoring Protein Titer and Glycosylation Simultaneously content piece image
Product
Advertisement

Monitoring Protein Titer and Glycosylation Simultaneously

Drug product glycosylation is a critical quality attribute (CQA) due to its potential impact on pharmacokinetics properties and stability of the product. The ability to view and choose from desired titer and glycosylation profiles at the same time provides more in-depth knowledge that facilitates more informed decisions.
Synthetic Immune Recruitment – A New Way To Fight Tumors content piece image
Product
Advertisement

Synthetic Immune Recruitment – A New Way To Fight Tumors

The utility and efficiency of the Octet® platform at characterizing covalent immune recruiter molecule function and their efficacy as modulators of protein proximity was demonstrated. Efficient in vitro validation further enables the potential acceleration of CIR translation to in vivo model validation and the clinic as a new class of synthetic tumor immunotherapeutic.
Advertisement